ABIONYX Pharma Announces Its Financial Agenda for the Year 2023 Read more about ABIONYX Pharma Announces Its Financial Agenda for the Year 2023
IntegraGen Reports €12.6m in Revenues for 2022 Representing 16% Growth Compared to 2021 and a Cash Position of €4.5m Read more about IntegraGen Reports €12.6m in Revenues for 2022 Representing 16% Growth Compared to 2021 and a Cash Position of €4.5m
Resolution on share capital increase in connection with exercise of Greenshoe Option Read more about Resolution on share capital increase in connection with exercise of Greenshoe Option
Share-based incentive program for key personnel Read more about Share-based incentive program for key personnel
BIOFISH HOLDING AS: PRIVATE PLACEMENT SUCCESSFULLY COMPLETED Read more about BIOFISH HOLDING AS: PRIVATE PLACEMENT SUCCESSFULLY COMPLETED
Scana ASA - Changes in the board and management Read more about Scana ASA - Changes in the board and management
Nordea Bank Abp: Repurchase of own shares on 12.01.2023 Read more about Nordea Bank Abp: Repurchase of own shares on 12.01.2023